SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-154578
Filing Date
2016-11-03
Accepted
2016-11-03 16:19:04
Documents
65
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17113_110q.htm 10-Q 1160787
2 EX-10.1(E) a16-17113_1ex10d1e.htm EX-10.1(E) 43182
3 EX-31.1 a16-17113_1ex31d1.htm EX-31.1 11660
4 EX-31.2 a16-17113_1ex31d2.htm EX-31.2 11582
5 EX-32.1 a16-17113_1ex32d1.htm EX-32.1 10195
12 GRAPHIC g171131kmi001.jpg GRAPHIC 4009
13 GRAPHIC g171131kmi002.jpg GRAPHIC 76430
14 GRAPHIC g171131kmi003.jpg GRAPHIC 154742
  Complete submission text file 0001104659-16-154578.txt   5316021

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT crvs-20160930.xml EX-101.INS 1042067
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crvs-20160930.xsd EX-101.SCH 39332
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crvs-20160930_cal.xml EX-101.CAL 51445
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crvs-20160930_def.xml EX-101.DEF 109581
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT crvs-20160930_lab.xml EX-101.LAB 372086
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crvs-20160930_pre.xml EX-101.PRE 257900
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37719 | Film No.: 161971850
SIC: 2834 Pharmaceutical Preparations